Roginolisib in Combination with JAK Inhibitors in Patients with Myelofibrosis Who are Unresponsive to Approved JAK Inhibitors (Study HEMA-MED) - A Trial in Progress.

Villarreal Hernandez J, Carbonero JOD, Paoli C, Guglielmelli P, Tiribelli M, Palandri F, Hernandez-Rivas JM, Fox ML, García de la Torre DC, Greenfield G, Rinaldi C, Sriskandarajah P, Harrison C, Pane F, Lanzarone G, Cilloni D, Pacilli M, Breccia M, Lahn M, Di Conza G, Hammett TC, Kaur P, Emig M, Tonge KM, Cantarini M, Polasek J, Lucchesi A, Santoro A, Vannucchi AM

Open source

DOI: 10.2147/ott.s631781
Published: 2026
Container: OncoTargets and therapy
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.2147/ott.s631781,
  title = {Roginolisib in Combination with JAK Inhibitors in Patients with Myelofibrosis Who are Unresponsive to Approved JAK Inhibitors (Study HEMA-MED) - A Trial in Progress.},
  author = {Villarreal Hernandez J and Carbonero JOD and Paoli C and Guglielmelli P and Tiribelli M and Palandri F and Hernandez-Rivas JM and Fox ML and García de la Torre DC and Greenfield G and Rinaldi C and Sriskandarajah P and Harrison C and Pane F and Lanzarone G and Cilloni D and Pacilli M and Breccia M and Lahn M and Di Conza G and Hammett TC and Kaur P and Emig M and Tonge KM and Cantarini M and Polasek J and Lucchesi A and Santoro A and Vannucchi AM},
  year = {2026},
  journal = {OncoTargets and therapy},
  doi = {10.2147/ott.s631781},
  url = {https://doi.org/10.2147/ott.s631781}
}

RIS

TY  - JOUR
TI  - Roginolisib in Combination with JAK Inhibitors in Patients with Myelofibrosis Who are Unresponsive to Approved JAK Inhibitors (Study HEMA-MED) - A Trial in Progress.
AU  - Villarreal Hernandez J
AU  - Carbonero JOD
AU  - Paoli C
AU  - Guglielmelli P
AU  - Tiribelli M
AU  - Palandri F
AU  - Hernandez-Rivas JM
AU  - Fox ML
AU  - García de la Torre DC
AU  - Greenfield G
AU  - Rinaldi C
AU  - Sriskandarajah P
AU  - Harrison C
AU  - Pane F
AU  - Lanzarone G
AU  - Cilloni D
AU  - Pacilli M
AU  - Breccia M
AU  - Lahn M
AU  - Di Conza G
AU  - Hammett TC
AU  - Kaur P
AU  - Emig M
AU  - Tonge KM
AU  - Cantarini M
AU  - Polasek J
AU  - Lucchesi A
AU  - Santoro A
AU  - Vannucchi AM
PY  - 2026
JO  - OncoTargets and therapy
DO  - 10.2147/ott.s631781
UR  - https://doi.org/10.2147/ott.s631781
ER  -

APA

J, V. H., JOD, C., C, P., P, G., M, T., F, P., JM, H., ML, F., DC, G. D. L. T., G, G., C, R., P, S., C, H., F, P., G, L., D, C., M, P., M, B., M, L., G, D. C., TC, H., P, K., M, E., KM, T., M, C., J, P., A, L., A, S., & AM, V. (2026). Roginolisib in Combination with JAK Inhibitors in Patients with Myelofibrosis Who are Unresponsive to Approved JAK Inhibitors (Study HEMA-MED) - A Trial in Progress.. OncoTargets and therapy. https://doi.org/10.2147/ott.s631781

Source records

pubmed · retrieved 2026-11-10T06:09:45.238Z